Publications de l'équipe EPSP
An iTRAQ Quantitative Proteomic Study to Reveal How Hypoxia in Tumor Micro-Environment Regulates Metabolic Reprogramming in A549 KRAS-Mutant Non-Small Cell Lung Cancer Cells upon Lysine Deacetylases Inhibitor Treatments to propose Machine-Learning-Based Drug Repositioning, - Archive ouverte HAL
Chapitre D'ouvrage Année : 2021

An iTRAQ Quantitative Proteomic Study to Reveal How Hypoxia in Tumor Micro-Environment Regulates Metabolic Reprogramming in A549 KRAS-Mutant Non-Small Cell Lung Cancer Cells upon Lysine Deacetylases Inhibitor Treatments to propose Machine-Learning-Based Drug Repositioning,

Josep Tarragó-Celada
Fichier non déposé

Dates et versions

hal-04837868 , version 1 (14-12-2024)

Identifiants

  • HAL Id : hal-04837868 , version 1

Citer

Alfonso Martín-Bernabé, Josep Tarragó-Celada, Valérie Cunin, Sylvie Michelland, Roldán Cortés, et al.. An iTRAQ Quantitative Proteomic Study to Reveal How Hypoxia in Tumor Micro-Environment Regulates Metabolic Reprogramming in A549 KRAS-Mutant Non-Small Cell Lung Cancer Cells upon Lysine Deacetylases Inhibitor Treatments to propose Machine-Learning-Based Drug Repositioning,. Immunology and Cancer: Advanced concepts, Vide Leaf, 2021. ⟨hal-04837868⟩
68 Consultations
0 Téléchargements

Partager

  • More